332 related articles for article (PubMed ID: 30865695)
1. Observational study on Swedish plaque psoriasis patients receiving narrowband-UVB treatment show decreased S100A8/A9 protein and gene expression levels in lesional psoriasis skin but no effect on S100A8/A9 protein levels in serum.
Duvetorp A; Söderman J; Assarsson M; Skarstedt M; Svensson Å; Seifert O
PLoS One; 2019; 14(3):e0213344. PubMed ID: 30865695
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum levels of calcium-binding S100 proteins A8 and A9 reflect disease activity and abnormal differentiation of keratinocytes in psoriasis.
Benoit S; Toksoy A; Ahlmann M; Schmidt M; Sunderkötter C; Foell D; Pasparakis M; Roth J; Goebeler M
Br J Dermatol; 2006 Jul; 155(1):62-6. PubMed ID: 16792753
[TBL] [Abstract][Full Text] [Related]
3. Stratum corneum levels of calprotectin proteins S100A8/A9 correlate with disease activity in psoriasis patients.
Matsunaga Y; Hashimoto Y; Ishiko A
J Dermatol; 2021 Oct; 48(10):1518-1525. PubMed ID: 34165193
[TBL] [Abstract][Full Text] [Related]
4. Biological therapy downregulates the heterodimer S100A8/A9 (calprotectin) expression in psoriatic patients.
D'Amico F; Granata M; Skarmoutsou E; Trovato C; Lovero G; Gangemi P; Longo V; Pettinato M; Mazzarino MC
Inflamm Res; 2018 Jul; 67(7):609-616. PubMed ID: 29605872
[TBL] [Abstract][Full Text] [Related]
5. S100A8 and S100A9 are messengers in the crosstalk between epidermis and dermis modulating a psoriatic milieu in human skin.
Lee Y; Jang S; Min JK; Lee K; Sohn KC; Lim JS; Im M; Lee HE; Seo YJ; Kim CD; Lee JH
Biochem Biophys Res Commun; 2012 Jul; 423(4):647-53. PubMed ID: 22683330
[TBL] [Abstract][Full Text] [Related]
6. Deletion of
Defrêne J; Berrazouane S; Esparza N; Pagé N; Côté MF; Gobeil S; Aoudjit F; Tessier PA
J Immunol; 2021 Feb; 206(3):505-514. PubMed ID: 33361205
[TBL] [Abstract][Full Text] [Related]
7. The expression of interleukin-22 and S100A7, A8, A9 mRNA in patients with psoriasis vulgaris.
Liu H; Huang K; Wu Y; Lin N; Li J; Tu Y
J Huazhong Univ Sci Technolog Med Sci; 2007 Oct; 27(5):605-7. PubMed ID: 18060647
[TBL] [Abstract][Full Text] [Related]
8. S100A8-S100A9 protein complex mediates psoriasis by regulating the expression of complement factor C3.
Schonthaler HB; Guinea-Viniegra J; Wculek SK; Ruppen I; Ximénez-Embún P; Guío-Carrión A; Navarro R; Hogg N; Ashman K; Wagner EF
Immunity; 2013 Dec; 39(6):1171-81. PubMed ID: 24332034
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 17 Promotes Expression of Alarmins S100A8 and S100A9 During the Inflammatory Response of Keratinocytes.
Christmann C; Zenker S; Martens L; Hübner J; Loser K; Vogl T; Roth J
Front Immunol; 2020; 11():599947. PubMed ID: 33643287
[TBL] [Abstract][Full Text] [Related]
10. S100A9 has a protective role in inflammation-induced skin carcinogenesis.
McNeill E; Hogg N
Int J Cancer; 2014 Aug; 135(4):798-808. PubMed ID: 24436096
[TBL] [Abstract][Full Text] [Related]
11. S100A8/A9 in Inflammation.
Wang S; Song R; Wang Z; Jing Z; Wang S; Ma J
Front Immunol; 2018; 9():1298. PubMed ID: 29942307
[TBL] [Abstract][Full Text] [Related]
12. Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies.
Wagner NB; Weide B; Gries M; Reith M; Tarnanidis K; Schuermans V; Kemper C; Kehrel C; Funder A; Lichtenberger R; Sucker A; Herpel E; Holland-Letz T; Schadendorf D; Garbe C; Umansky V; Utikal J; Gebhardt C
J Immunother Cancer; 2019 Dec; 7(1):343. PubMed ID: 31806053
[TBL] [Abstract][Full Text] [Related]
13. High serum S100A8/A9 levels and high cardiovascular complication rate in type 2 diabetics with ultrasonographic low carotid plaque density.
Hirata A; Kishida K; Nakatsuji H; Hiuge-Shimizu A; Funahashi T; Shimomura I
Diabetes Res Clin Pract; 2012 Jul; 97(1):82-90. PubMed ID: 22333479
[TBL] [Abstract][Full Text] [Related]
14. Increased serum levels and expression of S100A8/A9 complex in infiltrated neutrophils in atherosclerotic plaque of unstable angina.
Miyamoto S; Ueda M; Ikemoto M; Naruko T; Itoh A; Tamaki S; Nohara R; Terasaki F; Sasayama S; Fujita M
Heart; 2008 Aug; 94(8):1002-7. PubMed ID: 18308864
[TBL] [Abstract][Full Text] [Related]
15. Phagocyte-specific S100A8/A9 is upregulated in primary Sjögren's syndrome and triggers the secretion of pro-inflammatory cytokines in vitro.
Nicaise C; Weichselbaum L; Schandene L; Gangji V; Dehavay F; Bouchat J; Balau B; Vogl T; Soyfoo MS
Clin Exp Rheumatol; 2017; 35(1):129-136. PubMed ID: 27749214
[TBL] [Abstract][Full Text] [Related]
16. Substitution of methionine 63 or 83 in S100A9 and cysteine 42 in S100A8 abrogate the antifungal activities of S100A8/A9: potential role for oxidative regulation.
Sroussi HY; Köhler GA; Agabian N; Villines D; Palefsky JM
FEMS Immunol Med Microbiol; 2009 Jan; 55(1):55-61. PubMed ID: 19087201
[TBL] [Abstract][Full Text] [Related]
17. Association of S100A8/A9 with Lipid-Rich Necrotic Core and Treatment with Biologic Therapy in Patients with Psoriasis: Results from an Observational Cohort Study.
Berg AR; Hong CG; Svirydava M; Li H; Parel PM; Florida E; O'Hagan R; Pantoja CJ; Lateef SS; Anzenberg P; Harrington CL; Ward G; Zhou W; Sorokin AV; Chen MY; Teague HL; Buckler AJ; Playford MP; Gelfand JM; Mehta NN
J Invest Dermatol; 2022 Nov; 142(11):2909-2919. PubMed ID: 35750149
[TBL] [Abstract][Full Text] [Related]
18. S100a8/a9 Signaling Causes Mitochondrial Dysfunction and Cardiomyocyte Death in Response to Ischemic/Reperfusion Injury.
Li Y; Chen B; Yang X; Zhang C; Jiao Y; Li P; Liu Y; Li Z; Qiao B; Bond Lau W; Ma XL; Du J
Circulation; 2019 Aug; 140(9):751-764. PubMed ID: 31220942
[TBL] [Abstract][Full Text] [Related]
19. Comparison of mRNA, Protein, and Urinary Nucleic Acid Levels of S100A8 and S100A9 between Prostate Cancer and BPH.
Yun SJ; Yan C; Jeong P; Kang HW; Kim YH; Kim EA; Lee OJ; Kim WT; Moon SK; Kim IY; Choi YH; Kim WJ
Ann Surg Oncol; 2015 Jul; 22(7):2439-45. PubMed ID: 25348783
[TBL] [Abstract][Full Text] [Related]
20. S100A8/A9 stimulates keratinocyte proliferation in the development of squamous cell carcinoma of the skin via the receptor for advanced glycation-end products.
Iotzova-Weiss G; Dziunycz PJ; Freiberger SN; Läuchli S; Hafner J; Vogl T; French LE; Hofbauer GF
PLoS One; 2015; 10(3):e0120971. PubMed ID: 25811984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
